increased plasma cell number_Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish

http://metadb.riken.jp/0008097C57BL6TgH2LIL61KishTgH2LIL61KishTgH2LIL61KishTgH2LIL61Kish

increased plasma cell number_Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Tadamitsu Kishimoto
  http://metadb.riken.jp/db/mgi_rdf/MGI:3805998

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(H2-L-IL6)1Kish

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• C57BL/6-Tg(H2-L-IL6)1Kish

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased plasma cell number
  http://purl.obolibrary.org/obo/MP_0008097

文献

http://purl.org/net/cito/citesAsAuthority

• Asao. Katsume, et.al., Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice., Cytokine, 2002, 20
  http://rdf.ncbi.nlm.nih.gov/pubmed/12633573